The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Jeanne Mason Biography and Net Worth

SVP of Baxter International

Jeanne Mason, Ph.D. is senior vice president, Human Resources.

Mason joined Baxter in 2006 from GE Insurance Solutions, a primary insurance and reinsurance business, where she was responsible for global human resource functions. She began her career with General Electric in 1988 after service with the U.S. General Accounting Office in Washington, D.C. Her GE experience included leadership roles in Europe for GE Information Services and GE Capital Real Estate.

She received her bachelor's degree in psychology from Pitzer College, a master's degree in industrial psychology from American University and a Ph.D. in organizational psychology from George Washington University.

What is Jeanne K. Mason's net worth?: The estimated net worth of Jeanne K. Mason is at least $5.07 million as of January 17th, 2023. Dr. Mason owns 126,231 shares of Baxter International stock worth more than $5,067,543 as of April 26th. This net worth approximation does not reflect any other assets that Dr. Mason may own. Learn More about Jeanne K. Mason's net worth.
How do I contact Jeanne K. Mason?: The corporate mailing address for Dr. Mason and other Baxter International executives is One Baxter Parkway DF2-1W, Deerfield IL, 60015. Baxter International can also be reached via phone at (224) 948-2000 and via email at [email protected]. Learn More on Jeanne K. Mason's contact information.
Has Jeanne K. Mason been buying or selling shares of Baxter International?: Jeanne K. Mason has not been actively trading shares of Baxter International within the last three months. Most recently, Jeanne K. Mason sold 59,477 shares of the business's stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $44.70, for a transaction totalling $2,658,621.90. Following the completion of the sale, the senior vice president now directly owns 126,231 shares of the company's stock, valued at $5,642,525.70. Learn More on Jeanne K. Mason's trading history.
Who are Baxter International's active insiders?: Baxter International's insider roster includes Giuseppe Accogli (SVP), John Forsyth (Director), Andrew Frye (SVP), James Gavin, III (Director), Jacqueline Kunzler (SVP), Sean Martin (SVP), Jeanne Mason (SVP), Brian Stevens (CAO), and Albert Stroucken (Director). Learn More on Baxter International's active insiders.

Jeanne K. Mason Insider Trading History at Baxter International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2023	Sell	59,477	$44.70	$2,658,621.90	126,231
4/27/2020	Sell	47,146	$93.13	$4,390,706.98	163,485
1/31/2019	Sell	37,274	$72.00	$2,683,728.00
12/4/2017	Sell	33,350	$65.25	$2,176,087.50	124,609

Jeanne K. Mason Buying and Selling Activity at Baxter International

Baxter International Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Today's Range

Now: $40.15

$39.97

$40.42

50 Day Range

MA: $41.82

$39.47

$43.77

2 Week Range

Now: $40.15

$31.01

$50.21

Volume

2,013,206 shs

Average Volume

3,624,090 shs

Market Capitalization

$20.39 billion

P/E Ratio

7.69

Dividend Yield

2.83%

Beta

0.62

Move Your Money Before May 22

From Stansberry Research | Ad